Search Results - "Skupinska, M.M."

47P Integration of miRNA profiles and p53 mutations as biomarkers for predicting sensitivity and resistance to FGFR inhibitor CPL110 in cancer therapy by Skupinska, M.M., Walczak, M., Mikolajczyk, A., Wieczorek, M., Popiel, D.

Get full text

1409P Comparing different methods of FGFR1 aberrations analysis in squamous cell lung cancer (SqCLC) targeted therapy by Skupinska, M.M., Obtulowicz, T., Moes-Sosnowska, J., Rozy, A., Szczepulska, E., Langfort, R., Wynimko, J. Chorostowska, Stanczak, A., Pieczykolan, J., Wieczorek, M., Popiel, D.

Get full text

550P Preclinical characterization of CPL304110 as a potential selective inhibitor of fibroblast growth factors 1/2/3 in solid cancers by Popiel, D., Mikołajczyk, A., Skupinska, M.M., Hucz-Kalitowska, J., Stańczak, P., Piotrkowska, N., Yamani, A., Dubiel, K., Pieczykolan, J., Wieczorek, M., Stanczak, A.

Get full text

The role of FGFR2 amplification and expression in patients with advanced or metastatic gastric cancer receiving fluoropyrimidine-based chemotherapy by Skupinska, M.M., Jesiotr, M., Chrom, P., Mroz, A., Cierniak, S., Winiarek, M., Wyrwicz, L.S., Pieczykolan, J., Wieczorek, M., Stanczak, A., Bodnar, L.

Get full text

46O Preliminary results from a phase IA trial of selective FGFR1-3 inhibitor CPL304110 in patients with FGFR-deregulated advanced solid malignancies by Lugowska, I., Stanczak, A., Roszkowski, K., Dziadziuszko, R., Duchnowska, R., Kubiatowski, T., Bodnar, L., Szczylik, C., Chorostowska Wynimko, J., Popiel, D., Skupinska, M.M., Judycka, A., Rudzki, P., Pieczykolan, J., Wieczorek, M.

Get full text